产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 维生素K2粉

维生素K2粉

2024-11-15
2124-57-4
中国药典,美国药典
食品级

产品详情

维生素K2粉
维生素类
2124-57-4
中国药典,美国药典
食品级
维生素K2粉
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲

产品描述

CAS Number: 2124-57-4

Molecular Formula: C46H64O2

Formula Weight: 649.0

Appearance: White or pale yellow crystalline powder

Purity: 1000ppm; 2000ppm; 2500ppm; 10000ppm; 13000ppm; 20000ppm

Carrier: Cyclodextrin; Microcrystalline cellulose; Starch

Method: Fermentation

Vitamin K2 MK7 powder is a dietary supplement that contains the nutrient vitamin K2 in the form of menaquinone-7 (MK7). Vitamin K2 MK7 powder is a fat-soluble vitamin that plays an important role in regulating calcium metabolism and promoting bone and cardiovascular health.

MK7 is a specific form of vitamin K2 that is derived from the fermentation of soybeans or other plant sources. It is believed to be more bioavailable and have a longer half-life in the body than other forms of vitamin K2, making it an attractive ingredient for dietary supplements.

For instance, Vitamin K2 can be a great partner with calcium to improve bone and cardiovascular Health

Insufficient consumption of calcium can result in reduced bone mineral density, heightening the probability of bone fractures. Calcium supplementation can enhance bone mineral density and strength, thus preventing osteoporosis. Nevertheless, current scientific research implies that an excessive intake of calcium supplements may heighten the risk of heart disease and lead to hastened calcium accumulation in soft tissues and blood-vessel walls. Conversely, vitamin K2 has been linked to the inhibition of arterial stiffening and calcification. Adequate intake of vitamin K2 can minimize vascular damage by activating matrix GLA protein (MGP), which deters calcium deposits on walls. Vitamin K, particularly vitamin K2, is almost entirely absent in junk food and minimally consumed even in a nutritious Western diet. Inadequate activation of MGP resulting from vitamin K deficiency significantly hampers the process of calcium removal and raises the risk of blood-vessel calcification. Increasing vitamin K2 intake could potentially mitigate calcium-associated health hazards.

With advancements in manufacturing processes, the amount of vitamin K, specifically vitamin K2, found in today's food supply has significantly decreased. As a result, relying on vitamin K2 supplements is a more dependable method for ensuring sufficient intake.

Achieving a proper balance between calcium and K2 intake may help combat osteoporosis while also preventing the hardening and calcification of arteries.

广东新达瑞生物科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

广东新达瑞生物科技有限公司是一家研发驱动型高科技生物制药企业,致力于原创性新药及其核心中间体、高端原料药及其核心中间体的研发和商业化生产。公司符合美国FDA、欧盟EUGMP的质量管理要求,实践国际标准的药品质量管理规范和严格的药品生产管理体系,确保产品质量。 新达瑞生物积极实施人才战略,拥有生物制药行业高层次管理人才和技术团队,从而确保公司在生物制药领域有顽强的生命力和卓越的竞争力。 新达瑞生物以高效、环保、优质为原则,立足中国,放眼国际,以行业标杆要求自己,打造国际一流的生物医药供应商!
业务类型:
成立日期:
年营业额:
主营产品类别: